Menu

• Ask a Health Expert about CORONARY REVASCULARISATION
• Post Your Side Effect related to CORONARY REVASCULARISATION
• CORONARY REVASCULARISATION and FDA Warnings
• CORONARY REVASCULARISATION in Patients Wiki
• Report CORONARY REVASCULARISATION in Drug Side Effect Survey

CORONARY REVASCULARISATION side effect

What is CORONARY REVASCULARISATION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Telmisartan Side Effects Report #5547626-X
Consumer or non-health professional from reported TELMISARTAN problem on Dec 04, 2007. Female patient was diagnosed with hypertension and was treated with TELMISARTAN. After drug was administered, patient experienced the following problems/side effects: coronary revascularisation, myocardial infarction, percutaneous coronary intervention, . TELMISARTAN dosage: INITIAL DOSE 40 MG, DOSE DOUBLED DEPENDING ON BLOOD PRESSURE AND DIABETIC STATUS. During the same period patient was treated with ASPIRIN, CLOPIDOGREL, ATORVASTATIN, SIROLIMUS. Patient recovered.

Angiomax Side Effects Report #5290053-3
ANGIOMAX problem was reported by a Physician from ARGENTINA on Mar 19, 2007. Male patient, 55 years of age, weighting 205.0 lb, was treated with ANGIOMAX. After drug was administered, patient experienced the following problems/side effects: angina unstable, coronary revascularisation, in-stent arterial restenosis, . ANGIOMAX dosage: 69 MG, BOLUS, IV BOLUS. Patient recovered.

Gleevec Side Effects Report #5531559-9
Physician from BRAZIL reported GLEEVEC problem on Nov 27, 2007. Male patient, 70 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, cardiovascular disorder, coronary revascularisation, device breakage, osteomyelitis, osteoporosis, postoperative thoracic procedure complication, surgery, wound infection, . GLEEVEC dosage: unknown. Patient recovered.

Gleevec Side Effects Report #5528645-6
GLEEVEC problem was reported by a Physician from BRAZIL on Nov 22, 2007. Male patient, 70 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy, cardiovascular disorder, coronary revascularisation, device breakage, osteomyelitis, osteoporosis, postoperative thoracic procedure complication, surgery, wound infection, . GLEEVEC dosage: unknown. Patient recovered.